This interaction is consistent with known estrogen-mediated VEGF upregulation, extensively documented in hormonally responsive smooth muscle tumors, notably uterine leiomyomas [[16], [17], [18]]. The gene discussed is VEGFA; the disease is smooth muscle tumor.